Severe thrombocytopenia in Group-PS (6.5 x 104/μL) was significantly ameliorated by Anti-C5 administration (38.6 x 104/μL, P <0.01), and the inter-group difference was more pronounced in the long-term. This evidence concerns the gene C5 and Thrombocytopenia.